In a phase 2 randomised controlled trial, aspirin was well tolerated but failed to improve oxygenation index (OI) and physiological outcomes of lung injury or organ dysfunction in patients with acute ...
Q. A young man in our community nearly drowned recently. After he was rescued, he initially seemed fine, but then got very sick when his lungs filled with fluid while he was in the hospital.
ELK CITY, Idaho--(BUSINESS WIRE)--Therapeutic Solutions International announced today filing with the Food and Drug Administration (FDA) an amendment to its currently open Phase III clinical trial ...
In a review recently published in The Lancet Respiratory Medicine journal by Osuchowski et al. (May 6 th, 2021) the currently known pathophysiology of COVID-19 is laid out to describe the mechanistic ...
Emerging preclinical and clinical literature support MSCs may be appropriate to develop for COVID-19 as well as non-COVID-19 ARDS ImStem’s investigational MSC candidate IMS001, for which FDA recently ...
MENLO PARK, Calif., Dec. 09, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and ...
ALAMEDA, Calif. & FARMINGTON, Conn.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”: NYSE American: AGE), a biotechnology company developing therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback